Article
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
Clinical and vaccine immunology : CVI - 1 Mar 2011
Kristiansen Paul A, Diomandé Fabien, Wei Stanley C, Ouédraogo Rasmata, Sangaré Lassana, Sanou Idrissa, Kandolo Denis, Kaboré Pascal, Clark Thomas A, Ouédraogo Abdoul-Salam, Absatou Ki Ba, Ouédraogo Charles D, Hassan-King Musa, Thomas Jennifer Dolan, Hatcher Cynthia, Djingarey Mamoudou, Messonnier Nancy, Préziosi Marie-Pierre, LaForce Marc, Caugant Dominique A
Abstract excerpt
The serogroup A meningococcal conjugate vaccine MenAfriVac has the potential to confer herd immunity by reducing carriage prevalence of epidemic strains. To better understand this phenomenon, we initiated a meningococcal carriage study to determine the baseline carriage rate and serogroup distribution before vaccine introduction in the 1- to 29-year old population in Burkina Faso, the group chosen for the first...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
